Ascelia Pharma AB (OSTO:ACE) FFO


OSTO:ACE Ascelia Pharma AB OSTO:ACE
29 GF Score
Price kr3.08
! 1 Warning Sign
View Full Analysis

What is Ascelia Pharma AB FFO?

FFO (Funds from operations) only applies to REITs.

OSTO:ACE
29GF Score
Ascelia Pharma AB OSTO:ACE
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascelia Pharma AB Business Description

Other Exchanges ACEs:UK
Address Hyllie Boulevard 34, Malmo, SWE, 215 32
Ascelia Pharma AB is a biotech company focused on orphan oncology treatments. The company develops and commercializes novel drugs that address unmet medical needs and have a clear development and market pathway. It has two drug candidates, Orviglance and Oncoral, in development. Orviglance (manganese chloride tetrahydrate) is an oral contrast agent for MR imaging developed to improve the detection and visualization of focal liver lesions (including liver metastases and primary tumors) in patients with impaired kidney function, and Oncoral is a novel oral irinotecan tablet in development.
29GF Score

Get the complete analysis for OSTO:ACE

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.08
Price